GENSKEVA Trademark

Trademark Overview

On Friday, May 11, 2018, a trademark application was filed for GENSKEVA with the United States Patent and Trademark Office. The USPTO has given the GENSKEVA trademark a serial number of 87918238. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 21, 2022. This trademark is owned by Edenbridge Pharmaceuticals, LLC. The GENSKEVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of adult patients with mild to moderate type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option due to allergy, hypersensitivity, or poor venous access; Therapeutic pharmaceutical for the treatment of adult patients with mild to moderate type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option due to allergy, hypersensitivity, or poor venous access
genskeva

General Information

Serial Number87918238
Word MarkGENSKEVA
Filing DateFriday, May 11, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 21, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 20, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of adult patients with mild to moderate type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option due to allergy, hypersensitivity, or poor venous access; Therapeutic pharmaceutical for the treatment of adult patients with mild to moderate type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option due to allergy, hypersensitivity, or poor venous access
Translation of Words in MarkThe wording "GENSKEVA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, May 20, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEdenbridge Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameEdenbridge Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Tuesday, February 22, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 21, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, July 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 15, 2021SOU EXTENSION 5 GRANTED
Wednesday, July 7, 2021SOU EXTENSION 5 FILED
Thursday, July 15, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 7, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 8, 2021SOU EXTENSION 4 GRANTED
Friday, January 8, 2021SOU EXTENSION 4 FILED
Friday, January 8, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, October 7, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, July 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 9, 2020SOU EXTENSION 3 GRANTED
Thursday, July 9, 2020SOU EXTENSION 3 FILED
Thursday, July 9, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, January 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 10, 2020SOU EXTENSION 2 GRANTED
Friday, January 10, 2020SOU EXTENSION 2 FILED
Friday, January 10, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, July 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 12, 2019SOU EXTENSION 1 GRANTED
Friday, July 12, 2019SOU EXTENSION 1 FILED
Friday, July 12, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, June 26, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, January 15, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 20, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 31, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 2, 2018WITHDRAWN FROM PUB - OG REVIEW QUERY
Sunday, September 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 21, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 21, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 16, 2018ASSIGNED TO LIE
Friday, July 27, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 27, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 6, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 6, 2018NON-FINAL ACTION E-MAILED
Wednesday, June 6, 2018NON-FINAL ACTION WRITTEN
Tuesday, June 5, 2018ASSIGNED TO EXAMINER
Sunday, May 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 15, 2018NEW APPLICATION ENTERED

Related Keywords

genskeva therapeutic option therapy replacement allergy hypersensitivity access venous poor enzyme